Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...
WASHINGTON - Experts expressed enthusiasm after US health regulators approved the first new form of treatment for ...
US stocks closed another record-setting week with a muted performance, as hope built on Wall Street that the US economy can ...
Health and Me on MSN17h
Breakthrough in Schizophrenia Treatment: FDA Approves CobenfyNew drug offers hope for patients with Schizophrenia that has long eluded effective treatment. Read on to know more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback